Deep vein thrombosis
380 results
101 - 200Optimal algorithm for evaluating suspected DVT
Adults with varicose veins are at increased risk of DVT
Guidewire exchange of PICCs associated with higher risk of thrombosis
Surgery for deep venous insufficiency
Calf pain
Simple fibula fractures can be treated with splinting
Compression stockings = placebo stockings in preventing post-thrombotic syndrome (SOX)
Serial proximal vein ultrasonography + D-dimer = whole-leg Doppler for suspected leg DVT
Low risk of DVT after knee arthroscopy
USPSTF review of the benefits and harms of menopausal hormone therapy
Aspirin prevents recurrent venous thromboembolism
Chronic diseases and pregnancy
D-dimer vs ultrasound for DVT: use prediction rule
Wells score not helpful in hospitalized patients with suspected DVT
Leg oedema
Anticoagulants for people hospitalised with COVID‐19
Dalteparin = unfractionated heparin for ICU DVT prophylaxis
Thromboembolism recurrence likely; consider it a chronic disease (MARVELOUS)
Ultrasonographic examinations
Menopausal symptoms and hormone therapy
Combined intermittent pneumatic compression and pharmacological prophylaxis for prevention of venous thromboembolism
Rosuvastatin prevents DVT at very high cost
Stockings plus anticoagulation more effective to prevent post-op VTE, but anticoagulation increases bleeding
Oncological emergencies
Rivaroxaban effective for acute DVT (EINSTEIN)
Are inferior vena cava filters overused?
Approx 3% of PICC lines assoc with DVT, but no increase in PE
Direct oral anticoagulants
Fondaparinux effective for superficial thrombosis but at very high cost
Graduated compression stockings in the prevention of postoperative venous thromboembolism
Superficial venous thrombophlebitis
Sulodexide given long-term may reduce recurrent VTE in patients with initial unprovoked VTE
Prevention of venous thromboembolism
Venous insufficiency of the lower limbs
Whether warfarin is taken in the morning or the evening makes no meaningful difference in time in therapeutic range
Heparin for the prevention of venous thromboembolism in general medical patients (excluding stroke and myocardial infarction)
Baker's cyst
Interventions for preventing venous thromboembolism following abdominal aortic surgery
Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of pulmonary embolism
Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents
Antithrombotic agents in primary health care
Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement: Cochrane systematic review
Pulmonary embolism
Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism
Thrombophilia testing for prevention of recurrent venous thromboembolism
Anticoagulants for acute ischaemic stroke
Heparin for pregnant women with acquired or inherited thrombophilias
Genotype-guided perioperative warfarin dosing may not be superior to algorithm-guided dosing
Clinical rule to identify patients at low risk of recurrent VTE
Warfarin therapy
Patients with initial unprovoked DVT or PE benefit from long-term low-dose aspirin (INSPIRE)
Statins for primary prevention of venous thromboembolism: Cochrane systematic review
Anticoagulant and aspirin prophylaxis for preventing thromboembolism after major gynaecological surgery: Cochrane systematic review
CHIVA method for the treatment of chronic venous insufficiency
Evaluation of thrombophilia
Guidelines for managing VTE (AAFP, ACP)
Compression stockings ineffective after DVT
COVID-19 research briefs: High incidence of thrombotic events in patients hospitalized with COVID-19
Low-dose aspirin not useful for venous ulcers
IPC safer and as effective as medical prophylaxis; much better than TEDS
Cerebral infarction (ischaemic stroke)
Anaesthesia for hip fracture surgery in adults
Antiplatelet agents for the treatment of deep venous thrombosis
Nephrotic syndrome
Dabigatran safe and effective for VTE
Low rate of symptomatic VTE after elective knee arthroscopy
Early endovenous ablation improves outcomes in patients with venous leg ulcers
Neuromuscular electrical stimulation for the prevention of venous thromboembolism
Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism
Interrupted versus uninterrupted anticoagulation for cardiac rhythm management device insertion
Updated American College of Chest Physicians guideline on antithrombotic therapy for venous thromboembolism
Prolonged fever in the adult
Topical application of tranexamic acid for the reduction of bleeding
Compression therapy for prevention of post-thrombotic syndrome
Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy
Dabigatran versus LMWHs for thromboprophylaxis after total hip or knee replacement
Obesity not associated with adverse hip replacement outcomes